Blog
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates
MediWound (MDWD) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to a loss of $0.98 per share a year ago. These figures are
Bath & Body Works (BBWI) Lags Q3 Earnings and Revenue Estimates
Bath & Body Works (BBWI) came out with quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.49 per share a year ago. These
3 Top-Ranked Mutual Funds for Your Retirement
Investing in mutual funds for retirement is never too late. And the Zacks Mutual Fund Rank can be an excellent tool for investors looking to invest in the best funds.
How can you tell a good mutual
Make the Most of Your Retirement with These Top-Ranked Mutual Funds
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
How can you tell a good
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.
The easiest, most
Blue Dolphin Shares Sink as Q3 Loss Widens, Debt & ARO Costs Mount
Since it reported third-quarter 2025 earnings, shares of Blue Dolphin Energy Company BDCO have declined 35.9% compared with the S&P 500’s 3.9% decrease. Over the past month, the stock has dropped
Jacobs Solutions (J) Q4 Earnings and Revenues Beat Estimates
Jacobs Solutions (J) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.37 per share a year ago. These
Salesforce Bets on Data Cloud: Will This Offset Slowing Growth Trends?
Salesforce, Inc. CRM has been witnessing a slowing revenue growth trend over the past several quarters. After years of steady double-digit revenue increases, growth has cooled to single digits over
NVIDIA Stock Soars 6% as Q3 Earnings and Revenues Crush Estimates
NVIDIA Corporation NVDA shares gained nearly 6% during Wednesday’s extended trading session after the semiconductor behemoth reported better-than-expected third-quarter fiscal 2026 results.
EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth?
Embecta Corp. EMBC is set to release fourth-quarter fiscal 2025 results on Nov. 25, before the market opens.
Here’s a brief review of the company’s performance leading up to this announcement.
TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner
Thermo Fisher Scientific TMO recently introduced the Thermo Scientific SureTect Beverage Spoilage Multiplex qPCR assay. The assay is an industry-first all-in-one quantitative Polymerase Chain
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial
For Immediate Release
Chicago, IL – November 20, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength
Shares of ImmuCell Corporation ICCC have fallen sharply since the release of third-quarter 2025 earnings. The stock has declined 22.7% since the announcement compared with a 3.9% drop of the S&P 500
Maximus (MMS) Q4 Earnings and Revenues Lag Estimates
Maximus (MMS) came out with quarterly earnings of $1.62 per share, missing the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.46 per share a year ago. These figures are
The Zacks Analyst Blog Highlights Cisco Systems, Hewlett Packard Enterprise, Arista Networks and NVIDIA
For Immediate Release
Chicago, IL – November 20, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
NVIDIA-Led Relief Rally in Tech Sector? Undervalued ETFs in Focus
Global technology shares rallied on Nov. 20, 2025 as investors rotated back into AI-linked stocks following AI behemoth NVIDIA’s upbeat results. The tech space has been seesawing for quite some time
The Zacks Analyst Blog Highlights MS, VOO, SPY, IVV, SPYM, RSP, EQ and EQWL
For Immediate Release
Chicago, IL – November 20, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
Shoe Carnival (SCVL) Q3 Earnings Match Estimates
Shoe Carnival (SCVL) came out with quarterly earnings of $0.53 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.71 per share a year ago. These figures are
Atkore Inc. (ATKR) Q4 Earnings Miss Estimates
Atkore Inc. (ATKR) came out with quarterly earnings of $0.69 per share, missing the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $2.43 per share a year ago. These figures
BAC's Strategic AI Investments: Unlocking New Revenue Streams
Bank of America BAC is aggressively investing in artificial intelligence (AI) to boost productivity and create new revenue streams. With plans to allocate $4 billion from its $13 billion technology
POSCO Expands Lithium Supply Chain With Australia-Argentina Deals
POSCO Holdings, Inc. PKX recently announced a total investment of KRW 1.1 trillion to secure premium lithium resources in Australia and Argentina, strengthening its raw-material supply base for the
VNET Group (VNET) Q3 Earnings Match Estimates
VNET Group (VNET) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.06 per share a year ago. These figures are adjusted
Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
Eli Lilly and Company’s LLY stock crossed the $1000 per share mark for the first time on Nov. 12, reaching new highs. It is also fast nearing the $1 trillion market cap benchmark. The key driver of
3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns
At present, the markets are moving sideways as optimism and caution balance each other. Valuations are elevated near record highs, limiting upside, while mixed economic data and uncertain Federal



